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Objective. To describe the revision of a pharmacology course series taught over three quarters within a
Doctor of Pharmacy (PharmD) curriculum and assess changes in students’ attitudes toward and per-
formance after the revision.
Methods. Based in part on students’ dissatisfaction regarding a pharmacology course series, a course
director was hired and tasked with teaching a major portion of the course content, rewriting course
examinations, and facilitating active learning in the course series. Course evaluations and examination
scores of students who completed the course series after the implementation of the redesigned curric-
ulum (classes of 2015 and 2016) were assessed and compared with those of students who completed the
course before the revisions were made (classes of 2013 and 2014).
Results. Qualitative analysis of second-year pharmacy student evaluations identified a lack of inte-
gration and coordination within the pharmacology course sequence. Poor examination quality and the
absence of active teaching methods were other frequently described shortcomings of the pharmacology
curriculum. Course evaluations dramatically improved after shortcomings were addressed and stu-
dents’ performance in the subsequent therapeutics course also increased significantly.
Conclusion.Adding additional structure to and oversight for a pharmacology course series by adding a
course director improved student satisfaction with the course and improved performance in the sub-
sequent therapeutics course. This study highlights the importance of a well-designed pharmacology
curriculum for continued success in core courses in the PharmD curriculum.
Keywords: pharmacology, therapeutics, doctor of pharmacy degree, curriculum, course redesign
INTRODUCTION
According to the Accreditation Council for Phar-
macy Education (ACPE) Standards, Doctor of Pharmacy
(PharmD) degree program curricula should provide stu-
dents with knowledge from foundational sciences in a
format that allows them to solve therapeutic problems.1
Pharmacology bridges basic and clinical sciences by lay-
ing the foundational concepts required for the understand-
ing of patient-specific drug therapies.2 Although studies
have shown that knowledge of pharmacology is essential
for therapeutic rationale and decisionmaking, there are no
recommendations regarding a pharmacology course de-
sign that will optimally prepare students for clinical prob-
lem solving involving the therapeutic use of drugs.
Many schools, including pharmacy, medical, and
dental schools, have modified their pharmacology curric-
ulum in the past decadewith resultant increases in student
satisfaction.3-12 One strategy in these curricular modifi-
cations is to emphasize the importance of pharmacology
as an integrative science.5-8,11 Schools have shifted away
from teaching pharmacology, physiology, and therapeu-
tics in silos and toward teaching interdisciplinary curric-
ula that emphasizes the interrelatedness of basic and
clinical principles. One study reported high student satis-
faction when an interdisciplinary approach was used to
teach pharmacology topics in combination with physiol-
ogy topics in the neurosciences.11 In another study, me-
dicinal chemistry, pharmacology, andpharmacotherapeutics,
which are traditionally taught as separate courses, were in-
tegrated into one course sequence. Students were highly sat-
isfied with the integration process and stated that it enhanced
their learning experience.8 Integrating medicinal chemistry
andpharmacology into one entity also significantly increased
ratings on student course evaluations after the redesign.5
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Finally, another study used a case-oriented,multidisciplinary
format to teach pharmacology to second-year medical stu-
dents,which resulted in improved student satisfaction aswell
as improved class attendance.6 Aside from promoting phar-
macology as an integrative subject, other studies have re-
ported on implementing active-teaching modalities such as
team-based learning,9 problem-based learning,4 case-study
exercises,12 board games,13 and technology-based teaching
into pharmacology courses. The addition of team-based
learning, problem-based learning, and case-study exercises
to pharmacology courses all resulted inmore positive student
perceptions about the course, while technology-based teach-
ing led to increased student engagement10 and introductionof
a board game led to significantly improved pharmacology
examination scores.13
Based on student feedback, the Skaggs School of
Pharmacy and Pharmaceutical Sciences (SSPPS) modi-
fied its pharmacology curriculum by improving integra-
tion and coordination within the pharmacology course,
between each section of the pharmacology course series,
andwith the concurrent physiology courses. Furthermore,
active-teachingmodalities were introduced and questions
on course examinations were improved. The goal of these
modifications was to increase students’ mastery of the
integrated pharmacology material, thereby better prepar-
ing them for the therapeutics course. This paper describes
the changes made and determines whether these changes
increased student satisfaction with the pharmacology
course and translated into improved student performance
in therapeutics.
METHODS
Demographic data for students graduating from
SSPPS from 2013 through 2016 were obtained from
administrative records. Students’ age, gender, race/
ethnicity, major, and grade point average (GPA) were
compared between the different years. Undergraduate
majors were categorized into natural science, social sci-
ence, and undeclared/other. Race or ethnicity was cate-
gorized as African American, Asian, Hispanic, Native
American, white, and undeclared.
The pharmacology coursewas a required core course
for second-year pharmacy students. This course was first
implemented for the class of 2013 as a result of a major
curriculumchange in the school ofmedicine that removed
the shared pharmacology curriculum for medical and
pharmacy students. As a consequence, the school of phar-
macy had to implement its own pharmacology curricu-
lum. The pharmacology course operated for two years
before the redesign. This three-quarter course was pre-
dominantly lecture-based, with a total of 98 lecture hours.
Two examinations were administered each quarter,
resulting in a total of six examinations during the course.
Because of the relatively short timeframe in which this
course was created, multiple instructors were recruited to
teach. An average of 14 guest lecturers taught per quarter
for an average of 1.8 hours per lecturer.
With the redesign, the broad concepts taught in the
course did not change, but the organization and methods
of teaching were modified. In recognition of the need for
greater continuity within the course, a new faculty posi-
tion for a course director was created which focused en-
tirely on pharmacology education in the PharmD
curriculum.A licensed pharmacist with a PhD in the basic
scienceswas hired. This pharmacology educator provided
uniformity both as the course director and as a course
lecturer for multiple class sessions each quarter. This en-
sured that a consistent lecture format was used to provide
extensive links between new and previously learned ma-
terial and to more closely align course topics with those
taught in the concurrent physiology course series. The
number of guest lectures in the pharmacology course
was continuously reduced in the years following the re-
design, ie, there was an average of 12 guest lecturers per
quarter for the class of 2015 and an average of eight guest
lecturers per quarter for the class of 2016. Guest lecturers
taught an average of 2.1 hours per lecturer.
Examinations were completely rewritten to improve
their validity. Several factors that could potentially inter-
fere with themeaningful interpretation of test scores were
identified such as an absence of clear learning objectives
to link to multiple-choice questions (MCQs), a lack of an
examination blueprint, and the use of flawed MCQs. To
address these validity threats,14 clear learning objectives
were written and used to create an examination blueprint
to guide the construction of a well-balanced examination.
Multiple-choice questions containing flaws such as an
"unfocused stem" and "window dressing" were rewritten
so that they adhered to the best practices of MCQ writ-
ing.15 Test statistics were analyzed carefully to make sure
that item difficulty was appropriate and to identify and
remove nonfunctional options.16 Test score reliability
was calculated using the Kuder-Richardson Formula
20.17
Active teaching modalities were introduced with the
implementation of large-group problem-solving sessions.
In the first year following the curricular redesign, the
large-group sessions consisted primarily of examina-
tion-style multiple-choice practice questions. In subse-
quent years, the questions were converted away from
multiple-choice to more extensive application problems.
The revised application problems were designed with
three goals in mind: first, to help students review the
material already learned in class; second, to apply
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concepts taught in the lecture; and third, to allow students
to develop specific methods to approach complex phar-
macologic problems and provide practice in using those
methods. For each problem, students actively worked to-
gether in teams, assimilating knowledge, solving prob-
lems, and teaching one another for a set time. After the
student teams registered their answers, the course director
reviewed the problem to ensure all students understood
both the information and the problem-solving methods
used. The content as well as the number of total course
hours and the number of examinations did not change
significantly during the redesign.
To analyze the qualitative data gathered from re-
sponses to the open-ended question “what would you sug-
gest to improve the content or presentation of the course
material?” the primary investigator conducted an analysis
of all comments in multiple passes. Data analysis was
grounded in a theory-based approach.18 The primary in-
vestigator developed a coding scheme during the repeti-
tive reading of all comments. Resulting themes were
explored and defined during data analysis. As themes
emerged, they were abstracted to form categories.19
Second-year pharmacy students were surveyed over
four years (classes of 2013-2016) (two years prior to the
revisions and two years after). Students were asked to rate
their perceptions of course organization, communication,
and examinations, and the overall applicability of the
material among other aspects of the course using a 5-point
Likert scale (strongly disagree51 to strongly agree55).
Survey administration occurred after each quarter. Five
hundred eighty deidentified responses from second-year
pharmacy students were collected and analyzed. For ther-
apeutics course evaluations, third-year pharmacy students
were surveyed over four years, and 618 deidentified re-
sponses were collected and analyzed.
Therapeutics examination scores for the four classes
of pharmacy students were obtained from administrative
records. The 180-credit hour therapeutics course for third-
year pharmacy students was administered over three
quarters. The average therapeutics score was calculated
from all three final examinations for each student
(n5211). The therapeutic examinations consisted of
two patient cases integrating disease states taught during
the quarter followed by short-answer essay questions in
the following categories: signs and symptoms, risk factors
and etiologies, therapeutic rationale for drug selection,
drug dosing, therapeutic and toxic monitoring parame-
ters, and patient education. The final therapeutics exam-
ination was cumulative and remained unchanged in level
of difficulty and format over the study period. In contrast
to the objective therapeutics questions on the final exam-
ination, the therapeutics final grade included more sub-
jective elements, eg, participation points for attendance in
small group settings and an oral examination that in-
cluded a behavioral evaluation.
Statistical analysis was conducted using R statistical
software (R version 3.5.1, 2018 the R Foundation for
Statistical Computing),20 and GraphPad PRISM, version
5 (SanDiego, CA). Chi-square testswere used to compare
students by gender, race/ethnicity, and major of second-
year pharmacy students (classes of 2013-2016). Age at
admission and GPA were compared using one-way
ANOVA with Bonferroni post-test. Course characteris-
tics, course evaluations and therapeutics course perfor-
mance before and after the course redesign were
compared using an unpaired, two-tailed t test. The UC
San Diego Human Research Protection Program granted
Institutional Review Board approval.
RESULTS
All students who graduated from 2013 through 2016
were included in this study (n5211).Demographics of the
four student cohorts are summarized in Appendix 1. Stu-
dents were an average of 23 years old, 61% were Asian,
and had a mean admission GPA of 3.69 (SD50.15).
Ninety-seven percent of the students had earned an un-
dergraduate degree in the natural sciences before begin-
ning the Doctor of Pharmacy (PharmD) program. No
significant differences were found in age, gender, race/
ethnicity, undergraduate major, or GPA between the dif-
ferent student cohorts.
To critically evaluate the pharmacology course, stu-
dents’ suggestions for course improvements were ana-
lyzed. Course evaluations (n5155) collected from the
pharmacology course series before the redesign yielded
121 comments. The major themes that emerged from the
comments included the need to improve integration (eg,
better coordination of the lectures within the course and
better coordination of the course with other courses in the
curriculum); the need to improve examination quality;
and the need to add application-based teaching and learn-
ing modalities. Additionally, students requested that
goals and objectives be provided for every lecture, the
pharmacology content be more consistent, and delivery
of lectures be improved and lecture format be consistent
(Table 1).
To address the three major shortcomings identified
by students, several changes were made to the pharma-
cology course series. As indicated in Table 2, the percent-
age of course lectures taught by course directors increased
from15% to 43%.This increase reflects lectures taught by
the new course director overseeing the year-long course,
which allowed greater integration and coordination
within and between this course and other portions of the
American Journal of Pharmaceutical Education 2019; 83 (7) Article 6971.
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curriculum. In accordance, the percentage of lectures
taught by guest lecturers decreased. Although the percent
of courses taught by faculty members from the school of
pharmacy remained constant, there was a significant de-
crease in the percent of faculty members from outside the
school of pharmacy teaching in the course (Table 2). Re-
moving examination flaws and writing questions that
were more discriminating improved the examination val-
idity. Furthermore, the reliability coefficient as one indi-
cator of test quality increased from .62 to .74 after the
curricular change. The last entry in Table 2 documents
the introduction of large-group problem-solving sessions
to a total of 12% of the instructional hours. These sessions
provided an application-based teaching modality
requested by the students previously absent from the
course. The problem session provided students with ex-
perience in application of fundamental principles in com-
plex pharmacological responses or clinical settings,
which is an ongoing challenge.
To determine the impact of the redesigned course on
students’ satisfaction, course evaluations were analyzed
before and after the redesign. Whereas the data collected
Table 1. Pharmacy Students’ Responses When Asked, “What Would You Suggest to Improve the Content or Presentation of the
Course Material?” (Prior to Redesign)
Suggested Changes Examples
Total Student
Comments (%)
(n=121)
Integration/coordination
Appropriate coordination between
lectures within the course
“The lecturers need to be more aware of our background” 39 (32)
Appropriate coordination between this
course and other proportions of the
curriculum
“Would be helpful if material correlated timewise better with
other courses running at the same time.”
Examinations
Examination questions need to be
consistent with the learning objectives
“Make sure the exams also follow the learning objectives” 28 (23)
Improve exam question quality
“Have one person write all of the exam questions and make sure
they are relevant and well-worded”
Additional teaching and learning modalities
Introduction of teaching modalities that
facilitate the application of course
material
“As required in the course expectation, the materials should be
accompanied with case studies”
16 (13)
Introduction of learning modalities that
facilitate the retention of course
material
“Make it more clinically applicable”
Communication
Implementation of consistent goals and
objectives
“While some lecturers included learning objectives, the course
could be improved by standardizing the types of learning
objectives and including them in every lecture. Learning
objectives give structure to a study regiment and facilitate
active learning, rather than passive note-taking and reading”
15 (12)
“Consistent learning objective needed”
Content
Consistency in pharmacology content “Less physiology, more drug focus, but at the same time,
provide a more reasonable amount of details for the drugs”
15 (12)
Less emphasis on physiology
Delivery of lectures and lecture format
Better lecturers with excellent
presentation and communication skills
“The lecturers should be chosen based on how well they can
communicate the information to students. People who are
experts on certain topics do not always convey the
information well. It’s really hard for students to learn in that
environment.”
8 (7)
Consistent formatting of lecture slides
“More similarly formatted lectures (have some sort of standard
format for every lecture)”
American Journal of Pharmaceutical Education 2019; 83 (7) Article 6971.
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from the classes of 2013 and 2014 reflected students’ sat-
isfactionbefore the redesign, data collected from the classes
of 2015 and 2016 reflected students’ satisfaction after the
redesign. A total of 580 evaluations were collected from
each quarter of the pharmacology course over four years,
with an overall response rate of 84% (89% for the class of
2013, 87% for the class of 2014, 71% for the class of 2015
and 89% for the class of 2016). Items on the survey instru-
ment focused on course organization, communication, ex-
aminations, and the overall applicability of the material
among other aspects of the course. Course evaluations im-
proved significantly after the redesign of the pharmacology
course. The most dramatic increase was found for state-
ments related to the organization of the course, the clear
communication of course objectives and other require-
ments to successfully succeed in this course, fair examina-
tions, and the complete syllabus material (Table 3).
To explore whether the transformed pharmacology
curriculum had an impact on students’ learning and ap-
plication, therapeutics course performance was analyzed.
The therapeutics final examination performance signifi-
cantly increased from an average of 81.9% (SD55.2)
before the redesign (n5106) to an average of 83.6%
(SD54.9) after the pharmacology course redesign
(n5105; unpaired, two-tailed t test, p,.05). To ensure
that the analyzed student cohorts were similar in their
academic ability, students’ demographics and overall un-
dergraduateGPA (Appendix 1)were analyzed and did not
reveal significant differences. The therapeutics course
remained stable over the four-year study period, and no
major changes in format, organization, and delivery of the
material were identified. Course evaluations from 618
students were analyzed with an overall response rate of
90% (89% for the class of 2013, 91% for the class of 2014,
90% for the class of 2015, and 92% for the class of 2016).
Evaluation scores did not significantly change over the
study period (unpaired, two-tailed t test, Table 4).
DISCUSSION
Redesigning a pharmacology course series within a
PharmD curriculum significantly improved student satis-
faction with the course and student performance in the
subsequently taught therapeutics course. The redesign
addressed three key shortcomings: lack of integration
and coordination, poor examination quality, and lack of
active teaching modalities. Although there is no single
definition of “integration,” the individual educator is
key to integrating content within and between courses.21
At a minimum, integration requires the different faculty
members teaching within a course to communicate with
each other and to be aware of thematerial covered by their
colleagues.22 Many curricula are commonly flooded with
various subject matter experts who are “parachuted” into
courses for one or two guest lectures, never to be seen
again by the students. This approach is rooted in the idea
that each topic is best taught by a specialist in the field.
Four decades ago, Irby and colleagues described this as
the “parade of stars” model23 and this is still common-
place in health professions education. In fact, students
have indicated that the fewer teachers involved in a
course, the more evident the integration of course content
is.5 Integration is further improved by providing concep-
tual links between new and previously learned material,
and through an optimal sequencing of topics within the
course.21
In the curricular modification at SSPPS, these issues
were addressed by introducing a designated course direc-
tor for the course series. The director was experienced in
Table 2. Comparison of the Pharmacology Course Structure Before and After Redesigna
Before Course Redesign (Classes
of 2013 and 2014) Mean (SD)
After Course Redesign (Classes of
2015 and 2016) Mean (SD)
Improving integration/coordination
Percentage of teaching by Course Director (% of
total instructional hours)
15 (12) 43 (18)b
Percentage of teaching by School of Pharmacy
faculty (% of total instructional hours)
22 (8) 22 (11)
Percentage of teaching by other faculty outside
School of Pharmacy (% of total instructional hours)
63 (18) 35 (21)b
Improving exam quality
Reliability Coefficient 0.62 (0.11) 0.74 (0.06)b
Implementation of application-based teaching modalities
Percentage of large group problem solving sessions
per quarter (% of total instructional hours)
0 12 (6)b
a Comparison of the percentage of instructional hours taught by the course director, the exam’s reliability coefficient and the percentage of
problem-solving sessions in each quarter of the pharmacology course before (n56) and after the course design (n56). Unpaired, two-tailed t-test,
b p,.05
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the content of the pharmacology course and concurrent
courses, and taught a considerable portion of pharmacol-
ogy lectures. This allowed the director to identify and
emphasize connections between pharmacology lectures
throughout the year, as well as integrate course material
with material taught in concurrent courses.
In the redesigned pharmacology course, the course
director implemented large-group problem-solving ses-
sions to help bridge the difficult transition from basic
pharmacology principles taught in lecture and application
in clinical scenarios.Although it iswidely established that
the implementation of active-teaching modalities in-
creases students’ satisfaction, most foundational courses
such as pharmacology remain lecture-based.7,24,25 The
development of such active-teaching sessions is a time-
consuming task not easily achieved by faculty members
who have many other important clinical and/or research
responsibilities and clinical activities generally take
priority over faculty member teaching obligations.26
Investing significant resources to hire a professional phar-
macology educator allows a school to bypass this chal-
lenge and further justify the investment. Additionally, the
success of the redesign can be attributed to the training the
pharmacology educator had. In other words, a course
director who is a licensed pharmacist with PhD-level
training in health sciences has the ability to effectively
translate the basic foundational sciences to the clinical
care of patients. Through large-group problem-solving
sessions, the course director modeled the application of
pharmacology to therapeutics and provided the practice
needed for students to succeed in small group sessions
encountered in the therapeutics course series.
Students also identified poor examination quality as
one of the three top shortcomings of the course. Their
concerns included both poor quality questions and poor
correlation between the course content and the array of
questions on the examination. Examination questions
with unfocused stems and heterogeneous answers are
considered flawed,15 and such flawed examination ques-
tionsmay decrease the reliability of examination scores.14
Also, the frustration associated with answering flawed
questions and questions poorly correlated with presented
material decreases student satisfaction. The new course
director rewrote all course assessments to eliminate
flawed questions and to link questions with the revised
learning objectives. The learning objectives were also re-
vised at the time of the course redesign, allowing a better
linkage of examination questions to specific learning ob-
jectives. The relative difficulty and number of questions
for each examination remained unchanged. Reliability
measures were analyzed to determine the reproduc-
ibility of the examination scores. Notably, the reliability
Table 3. Students’ Perceptions of the Pharmacology Course Before (Class of 2013-2014) and After the Redesign (Class of 2015-
2016)a
Pharmacology Evaluation
Scores (Class of 2013-2014)
Pharmacology Evaluation
Scores (Class of 2015-2016)
Statements Mean (SD) Mean (SD)
The course material was intellectually stimulating. 3.8 (0.1) 4.4 (0.2)b
The course policies and requirements (grading,
assignments, attendance, etc.) were clear.
3.5 (0.4) 4.6 (0.2)b
The course was well planned and organized. 3.2 (0.4) 4.4 (0.3)b
The course objectives were clearly stated. 3.4 (0.4) 4.5 (0.2)b
Laboratory and/or workshop sessions were well
planned and contributed to meeting the course objectives.
3.7 (0.2) 4.4 (0.2)b
Homework assignments were reasonable in number
and contributed to an understanding of the course material.
3.8 (0.1) 4.4 (0.2)b
The required reading was useful in understanding the
course material.
3.6 (0.1) 4.2 (0.4)b
Examinations were fair and representative of the
course material presented.
3.5 (0.3) 4.4 (0.3)b
The syllabus materials were complete and enhanced
the learning process.
3.4 (0.2) 4.4 (0.2)b
Correlations were provided that demonstrated the
applicability of the material presented.
3.7 (0.2) 4.5 (0.2)b
a Mean evaluation scores from every quarter from a total of 580 students (response rate 84%) were analyzed before (n56) and after the course
design (n56). Responses based on a Likert scale of 1 to 5 where 15strongly disagree, 25disagree, 35neither agree or disagree, 45agree,
55strongly agree
b p,.05, unpaired, two-tailed t-test
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coefficient of examinations improved, and student satis-
faction with the examinations improved as well.
There are several limitations to this study. First and
foremost, student performance in the subsequent thera-
peutics course may have improved because of factors
other than the pharmacology course redesign. Although
students’ demographics and overall undergraduate GPA
did not significantly vary between the different classes
included in this study, subjective factors such as students’
motivation, background, and learning abilities may have
affected their engagement and performance in the
PharmD curriculum. Although we believe that other
courses in the second- and third-year curriculum
remained stable, there may have been subtle curricular
changes made to those courses that we were not aware
of. Second, this study focused only on student satisfaction
in the pharmacology course and performance in therapeu-
tics as outcomes of the pharmacology course redesign.
Theremayhave been other outcomes that could have been
analyzed, such as performance on a cumulative high-
stakes examination or performance in other courses.
However, as described in theACPE standards, knowledge
from the foundational sciences such as pharmacology
needs to be applied in order to solve therapeutics prob-
lems.1 Hence, concepts in pharmacology are fundamental
to pharmacists’ understanding of therapeutics and their
ability to choose one therapeutic regimen over another.2
Therefore, we believed that therapeutics mastery was
closely linked to pharmacology and that students’ ability
to apply pharmacological concepts could be best assessed
in the therapeutics course. Lastly, this study was conduct-
ed at a single institution, and thus the results might be not
generalizable to other institutions.
CONCLUSION
The introduction of a course director responsible for
overseeing the entire pharmacology curriculum resulted
in improved student satisfaction within the course series
and ensured that students developed a strong foundational
knowledge of pharmacological principles. These results
support the use of pharmacology educators in courses
teaching foundational content that is critical to therapeu-
tic decision-making.
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55strongly agree. Comparisons between different evaluation scores of the Class of 2013-2014 and the Class of 2015-2016 were conducted using
an unpaired, two-tailed t-test. No significant differences between any of the statements were detected
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Appendix 1. Demographics of Students in PharmD Curriculum Before (Class of 2013 and 2014) and After (Class of 2015 and 2016)
Redesign of the Pharmacology Curriculum
Characteristic Class of 2013 Class of 2014 Class of 2015 Class of 2016
Age at admission, Mean (SD) 24 (3) 23 (3) 23 (3) 23 (2)
Gender, n (%)
Male 16 (29) 10 (20) 20 (39) 18 (33)
Female 40 (71) 40 (80) 31 (61) 36 (67)
Race/Ethnicity, n (%)
African American 2 (4) 0 0 1 (2)
Asian 31 (55) 32 (64) 32 (63) 33 (61)
Hispanic 2 (4) 0 1 (2) 1 (2)
Native American 0 1 (2) 0 0
White 11 (20) 8 (16) 17 (33) 18 (33)
Undeclared 10 (18) 9 (18) 1 (2) 1 (2)
Major, n (%)
Natural Science 56 (100) 47 (94) 49 (96) 50 (92)
Social Science 0 2 (4) 1 (2) 2 (4)
Undeclared/Other 0 1 (2) 1 (2) 2 (4)
GPA, Mean (SD) 3.68 (0.16) 3.72 (0.13) 3.68 (0.14) 3.68 (0.15)
a Comparisons between different classes of students was conducted using 1-way ANOVA with Bonferroni post-test (for continuous variables) and
chi-squared tests (for categorical variables). No significant differences between any of the variables were detected. Undeclared ethnicity was
excluded as a categorical variable for statistical analysis
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